United Therapeutics Remodulin Efficacy Shown By Secondary Data - Cmte.
Executive Summary
United Therapeutics' Remodulin efficacy may be based on secondary measures rather than primary endpoints because the pulmonary arterial hypertension therapy will be prescribed for a small population, FDA's Cardiovascular & Renal Drugs Advisory Committee agreed at its Aug. 9 meeting.